NCT07044648

Middle Meningeal Artery Embolization for Chronic Migraine

Middle Meningeal Artery Embolization for Treatment of Chronic Migraine: A Pilot Study

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Wake Forest University Health Sciences · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The main goal of this study is to find out how well middle meningeal artery coil embolization works for patients with recurrent chronic migraines that are not resolved with medication.

Detailed description

This study seeks to evaluate the therapeutic potential of middle meningeal artery coil embolization as an interventional strategy for patients with recurrent and pharmacoresistant chronic migraine. Middle meningeal artery embolization has recently gained recognition as a safe and effective intervention for the management of chronic subdural hematoma, demonstrating a low complication profile. The procedure achieves therapeutic effect by reducing or occluding arterial flow within the middle meningeal artery, thereby minimizing arterial dilatation and facilitating hematoma resorption over time.

Conditions

• Migraine

Interventions

Type	Name	Description
PROCEDURE	Middle Meningeal Artery Embolization	Middle meningeal artery embolization using particles or coils

Timeline

• Start date: 2026-02-01
• Primary completion: 2027-08-01
• Completion: 2027-08-01
• First posted: 2025-07-01
• Last updated: 2026-02-06